5 Things You’ll Want to Know About What Could Be the Biggest Medical Marijuana Drug Ever

Only three drugs based on marijuana have ever been approved by the U.S. Food and Drug Administration (FDA). None of those drugs were actually made from marijuana plants but were instead created using synthetic versions of cannabinoids. None of them have been huge commercial successes either. But a cannabinoid drug that’s actually made from marijuana plants and has blockbuster sales potential could soon win approval.

The FDA is scheduled to make a decision by June 27, 2018, on GW Pharmaceuticals(NASDAQ:GWPH) cannabidiol (CBD) drug Epidiolex as a treatment for Dravet syndrome and Lennox-Gastaut syndrome (LGS). An FDA advisory committee already unanimously recommended approval for the cannabinoid drug. 

Epidiolex is widely expected to be a big seller. Market research firm Evaluate Pharma projects that it will be one of the 10 biggest new drugs launched in 2018, with sales around $1 billion by 2022. 

With the countdown on for the anticipated

... read more at: https://www.fool.com/investing/2018/05/17/5-things-youll-want-to-know-about-what-could-be-th.aspx